130 related articles for article (PubMed ID: 38605473)
21. Actinic keratosis area and severity index is not correlated with photodynamic therapy procedural pain.
Sharma A; Vincent L
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101946. PubMed ID: 32795507
[TBL] [Abstract][Full Text] [Related]
22. Diclofenac Sodium 3% in Hyaluronic Acid 2.5% Gel Significantly Diminishes the Actinic Keratosis Area and Severity Index.
Schmitz L; Gupta G; Segert MH; Kost R; Sternberg J; Gambichler T; Stockfleth E; Dirschka T
Skin Pharmacol Physiol; 2018; 31(4):206-211. PubMed ID: 29791916
[TBL] [Abstract][Full Text] [Related]
23. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.
Wiegell SR; Fabricius S; Gniadecka M; Stender IM; Berne B; Kroon S; Andersen BL; Mørk C; Sandberg C; Ibler KS; Jemec GB; Brocks KM; Philipsen PA; Heydenreich J; Hædersdal M; Wulf HC
Br J Dermatol; 2012 Jun; 166(6):1327-32. PubMed ID: 22250644
[TBL] [Abstract][Full Text] [Related]
24. Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action.
Schlesinger T; Stockfleth E; Grada A; Berman B
Clin Cosmet Investig Dermatol; 2022; 15():2495-2506. PubMed ID: 36415541
[TBL] [Abstract][Full Text] [Related]
25. A randomized trial comparing simultaneous vs. sequential field treatment of actinic keratosis with ingenol mebutate on two separate areas of the head and body.
Pellacani G; Peris K; Guillen C; Clonier F; Larsson T; Venkata R; Puig S
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2192-8. PubMed ID: 26300464
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of follow-up field treatment of actinic keratosis with ingenol mebutate 0·015% gel: a randomized, controlled 12-month study.
Garbe C; Basset-Seguin N; Poulin Y; Larsson T; Østerdal ML; Venkata R; Lear JT
Br J Dermatol; 2016 Mar; 174(3):505-13. PubMed ID: 26471889
[TBL] [Abstract][Full Text] [Related]
27. The clinical efficacy of topical methyl-aminolevulinate photodynamic therapy in moderate to severe actinic keratoses of the face and scalp.
Kleinpenning MM; van de Kerkhof PC; Gerritsen RM
J Dermatolog Treat; 2010 Jul; 21(4):252-7. PubMed ID: 19832288
[TBL] [Abstract][Full Text] [Related]
28. Early clinical response to 5-fluorouracil 0.5% and salicylic acid 10% topical solution in the treatment of actinic keratoses of the head: an observational study.
Garofalo V; Geraci F; Di Prete M; Lanna C; Lozzi F; Cosio T; Lambiase S; Gaeta Shumak R; Di Raimondo C; Diluvio L; Bianchi L; Campione E
J Dermatolog Treat; 2022 Aug; 33(5):2664-2669. PubMed ID: 35435128
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness, safety and satisfaction of 1% tirbanibulin ointment in the treatment of actinic keratoses: A prospective study in real clinical practice.
Mansilla-Polo M; Abril-Pérez C; Martín-Torregrosa D; López-Davia J; de Unamuno-Bustos B; Torres-Navarro I; Escutia-Muñoz B; Botella-Estrada R
Australas J Dermatol; 2023 Nov; 64(4):560-564. PubMed ID: 37675890
[No Abstract] [Full Text] [Related]
30. Patient- and Clinician-Reported Outcomes for Tirbanibulin in Actinic Keratosis in Clinical Practice Across the United States (PROAK).
Schlesinger T; Kircik L; Lebwohl M; Patel VA; Berman B; Bhatia N; Rigel D; Armstrong A; Rosso JD; Narayanan S; Koscielny V
J Drugs Dermatol; 2024 May; 23(5):338-346. PubMed ID: 38709702
[TBL] [Abstract][Full Text] [Related]
31. Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient randomized trial.
Gutiérrez García-Rodrigo C; Pellegrini C; Piccioni A; Tambone S; Fargnoli MC
Photodiagnosis Photodyn Ther; 2019 Sep; 27():100-104. PubMed ID: 31141730
[TBL] [Abstract][Full Text] [Related]
32. Physician-patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directed therapy for the treatment of actinic keratosis in Italy.
Neri L; Peris K; Longo C; Calvieri S; Frascione P; Parodi A; Eibenschuz L; Bottoni U; Pellacani G;
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):93-107. PubMed ID: 29920789
[TBL] [Abstract][Full Text] [Related]
33. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
Swanson N; Smith CC; Kaur M; Goldenberg G
J Drugs Dermatol; 2014 Feb; 13(2):166-9. PubMed ID: 24509967
[TBL] [Abstract][Full Text] [Related]
34. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3 multicenter, randomized, double-blind, placebo-controlled studies.
Swanson N; Smith CC; Kaur M; Goldenberg G
J Drugs Dermatol; 2013 Nov; 12(11):1278-82. PubMed ID: 24196337
[TBL] [Abstract][Full Text] [Related]
35. Comparative Efficacy and Safety of Tirbanibulin for Actinic Keratosis of the Face and Scalp in Europe: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Heppt MV; Dykukha I; Graziadio S; Salido-Vallejo R; Chapman-Rounds M; Edwards M
J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329979
[TBL] [Abstract][Full Text] [Related]
36. Contact Sensitization and Phototoxic and Photoallergic Potential of Tirbanibulin 1% Ointment in Healthy Volunteers.
Dosik J; Cutler DL; Fang J; Padullés L
JID Innov; 2023 Mar; 3(2):100170. PubMed ID: 36699198
[TBL] [Abstract][Full Text] [Related]
37. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
[TBL] [Abstract][Full Text] [Related]
38. Patient and physician satisfaction in an observational study with methyl aminolevulinate daylight photodynamic therapy in the treatment of multiple actinic keratoses of the face and scalp in six European countries.
Fargnoli MC; Ibbotson SH; Hunger RE; Rostain G; Gaastra MTW; Eibenschutz L; Cantisani C; Venema AW; Medina S; Kerrouche N; Pérez-Garcia B
J Eur Acad Dermatol Venereol; 2018 May; 32(5):757-762. PubMed ID: 29136306
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Actinic Keratosis and Severity Index with Physician Global Assessment and Total Lesion Count and the Ability to Predict Skin Cancer.
Acar A; Karaarslan I
Dermatol Pract Concept; 2022 Feb; 12(1):e2022031. PubMed ID: 35223175
[TBL] [Abstract][Full Text] [Related]
40. Non-invasive monitoring of subclinical and clinical actinic keratosis of face and scalp under topical treatment with ingenol mebutate gel 150 mcg/g by means of reflectance confocal microscopy and optical coherence tomography: New perspectives and comparison of diagnostic techniques.
Ruini C; Hartmann D; Bastian M; Ruzicka T; French LE; Berking C; von Braunmühl T
J Biophotonics; 2019 Jul; 12(7):e201800391. PubMed ID: 30653833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
